GH Research drops on $150 mln equity raise for depression treatments

GH Research

05/02/2025 13:59

**  Shares of GH Research  GHRS.O  down 3.2% premarket to
$15.79 after securing equity raise
  
    ** Irish biotech firm late Tues  10 mln shares at $15 for
$150 mln gross proceeds
  
    ** Offering price represents 8.1% discount to stock's last
sale of $16.32. Stock fell 9.3% on Tues
  
    ** On Mon, GHRS shares 
    
      
    
  
    
      
    
    net offering proceeds to invest in research,
clinical/technical development of current and/or additional
product candidates, according to the 
    SEC filing
  
    ** It has 
  
    ** Cantor, Stifel and RBC are jt bookrunners for the
offering
  
    ** Sentiment on GHRS heir median PT is $37, according to
LSEG data
  
    
      
    
  

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))